hydroxyl radical has been researched along with 5-((4-prop-2-ynylpiperazin-1-yl)methyl)quinolin-8-ol in 1 studies
| Studies (hydroxyl radical) | Trials (hydroxyl radical) | Recent Studies (post-2010) (hydroxyl radical) | Studies (5-((4-prop-2-ynylpiperazin-1-yl)methyl)quinolin-8-ol) | Trials (5-((4-prop-2-ynylpiperazin-1-yl)methyl)quinolin-8-ol) | Recent Studies (post-2010) (5-((4-prop-2-ynylpiperazin-1-yl)methyl)quinolin-8-ol) |
|---|---|---|---|---|---|
| 10,147 | 26 | 3,657 | 10 | 0 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bar-Am, O; Fridkin, M; Gal, S; Warshawsky, A; Weiner, LM; Youdim, MB; Zheng, H | 1 |
1 other study(ies) available for hydroxyl radical and 5-((4-prop-2-ynylpiperazin-1-yl)methyl)quinolin-8-ol
| Article | Year |
|---|---|
Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition.
Topics: Animals; Antioxidants; Cell Survival; Culture Media, Serum-Free; Cysteine; Designer Drugs; Hydroxyl Radical; Hydroxyquinolines; Iron Chelating Agents; Lipid Peroxidation; Monoamine Oxidase Inhibitors; Neurodegenerative Diseases; Neuroprotective Agents; Oxidopamine; PC12 Cells; Piperazines; Rats | 2005 |